Nerve Repair and Re generation Sales

Nerve Repair and Regeneration Sales Market Outlook

The global Nerve Repair and Regeneration market is projected to reach USD 14.8 billion by 2035, growing at a CAGR of 10.6% during the forecast period of 2025–2035. This growth is primarily driven by the rising incidence of neurological disorders, increasing geriatric population, and advancements in surgical techniques and technologies. The demand for effective treatments to address nerve injuries and diseases, coupled with an increasing focus on regenerative medicine, is further fueling market expansion. Moreover, the growing awareness of nerve repair and regeneration therapies and the rise in healthcare expenditures are contributing factors to the market's robust trajectory. As the global healthcare landscape evolves, innovative solutions and products are being developed to enhance nerve regeneration outcomes, reflecting a significant shift towards personalized medicine in neurology.

Growth Factor of the Market

The Nerve Repair and Regeneration market is witnessing substantial growth due to several converging factors. One of the most significant drivers is the increasing prevalence of neurological disorders such as Parkinson's disease, multiple sclerosis, and peripheral neuropathy, which necessitate advanced treatment options. Additionally, the geriatric population is projected to rise, leading to a higher incidence of nerve injuries and disorders associated with aging, thereby boosting market demand. Furthermore, technological advancements in nerve repair products, such as nerve conduits and neuromodulation devices, have enhanced the efficacy of treatments, contributing to improved patient outcomes. The growing focus on research and development in regenerative medicine, primarily involving stem cells and nerve growth factors, is paving the way for the introduction of innovative therapies. Lastly, the rising healthcare awareness, coupled with an increasing number of surgical procedures, is also propelling the growth of the Nerve Repair and Regeneration market.

Key Highlights of the Market

• Projected growth to USD 14.8 billion by 2035 with a CAGR of 10.6%
• Increasing incidence of neurological disorders driving demand for nerve repair solutions
• Technological advancements enhancing effectiveness and safety of nerve repair products
• Growing emphasis on regenerative medicine, including stem cells and nerve growth factors
• Expansion of healthcare infrastructure supporting increased surgical procedures globally

By Product Type

Nerve Conduits:

Nerve conduits are essential devices used in nerve repair surgeries, designed to facilitate the regeneration of damaged nerves. These conduits serve as scaffolding for nerve fibers, promoting healing and restoring functionality. They are generally made from biocompatible materials that support cellular attachment and migration. The rise in traumatic injuries and surgeries related to nerve damage significantly contributes to the demand for nerve conduits. Moreover, advancements in biomaterials have led to the development of conduits that can enhance nerve regeneration rates, making them an attractive option for surgeons. The increasing preference for minimally invasive surgical techniques is also bolstering the use of nerve conduits in clinical settings.

Nerve Protectors:

Nerve protectors are critical in safeguarding peripheral nerves during surgical procedures and in the postoperative phase. These devices play a vital role in preventing nerve damage from external stressors, inflammation, and scar tissue formation. The growing recognition of the importance of nerve protection, particularly in neurosurgery and orthopedic surgery, has led to an upswing in product innovation and usage. The demand for nerve protectors is further propelled by advancements in materials science that allow for more effective and safer products. As surgical procedures become more sophisticated, the incorporation of nerve protectors is becoming standard practice in various specialties.

Nerve Wraps:

Nerve wraps are specialized products designed to encase damaged nerves, providing protection and support during the healing process. These wraps are typically made from flexible, biocompatible materials that allow for nerve movement while preventing further injury. The market for nerve wraps is growing due to an increase in nerve repair surgeries and a heightened understanding of their role in postoperative recovery. Clinical studies demonstrating improved recovery outcomes with nerve wraps are further solidifying their adoption in surgical protocols. Additionally, the development of customizable nerve wraps tailored to individual patient needs is enhancing their appeal among healthcare providers.

Nerve Connectors:

Nerve connectors are innovative products designed to facilitate the direct connection of severed nerve fibers. These devices provide an efficient solution for nerve repair, promoting faster and more effective regeneration. The increasing incidence of traumatic injuries and surgeries that necessitate nerve reconnection is driving the demand for nerve connectors. Moreover, advancements in bioengineering have led to the creation of connectors that minimize scarring and promote optimal healing conditions. As surgical techniques evolve, the incorporation of nerve connectors into standard procedures is expected to become more prevalent, further incentivizing market growth.

Neuromodulation Devices:

Neuromodulation devices represent a significant advancement in the field of nerve repair and regeneration, offering non-invasive and invasive options to alleviate pain and restore nerve functionality. These devices utilize electrical stimulation to modulate nerve activity, promoting healing and functional recovery. The growing prevalence of chronic pain conditions and neurological disorders is increasing the adoption of neuromodulation therapies. Additionally, ongoing research into the efficacy of these devices in various applications is broadening their potential market reach. As patients and healthcare providers seek alternatives to pharmacological interventions, the demand for neuromodulation devices in nerve repair contexts is expected to rise.

By Application

Neurosurgery:

Neurosurgery is a prominent application area for nerve repair and regeneration products, involving surgical interventions to treat various neurological conditions. The demand for nerve repair solutions in neurosurgery is driven by the increasing prevalence of brain and spinal cord injuries, tumors, and congenital disorders. As surgical techniques advance and become more refined, the need for effective nerve repair products grows. Additionally, the rise in awareness regarding postoperative care and recovery is leading to a greater emphasis on utilizing innovative products that promote nerve healing. Neurosurgeons are increasingly incorporating nerve conduits and wraps into their surgical protocols, leading to improved patient outcomes and enhanced recovery times.

Orthopedic Surgery:

Orthopedic surgery is another significant application segment, as nerve injuries often occur in conjunction with musculoskeletal injuries. The integration of nerve repair solutions in orthopedic procedures is essential for restoring function and alleviating pain. As the global incidence of orthopedic conditions rises, driven by factors such as sports injuries, aging populations, and obesity, the demand for nerve repair products in this field is expected to grow. The development of specialized products, such as nerve wraps and protectors, tailored for orthopedic applications is facilitating better surgical outcomes. Furthermore, the collaboration between orthopedic surgeons and neuroscientists is leading to innovations that enhance nerve repair processes across this specialty.

Wound Healing:

The application of nerve repair products in wound healing is gaining traction, particularly for chronic wounds and post-surgical recovery. Nerve injuries can significantly impede the healing process, making effective nerve repair essential for optimal wound healing. The increasing prevalence of diabetic ulcers and venous leg ulcers is driving the adoption of nerve repair solutions in this area. Advanced wound care products that incorporate nerve growth factors and stem cells are emerging, showcasing the potential for synergistic healing effects. As healthcare providers increasingly recognize the importance of nerve health in wound recovery, the market for nerve repair products in wound healing is expected to expand significantly.

Others:

Aside from the primary applications of neurosurgery, orthopedic surgery, and wound healing, there are several other emerging applications for nerve repair products. These include cosmetic surgery, dental surgery, and trauma care, where nerve damage can significantly impact recovery and functional outcomes. The versatility of nerve repair solutions, such as conduits and protectors, allows for their use across various surgical specialties. As the understanding of nerve repair and regeneration evolves, new opportunities for these products are likely to arise in diverse applications. The ongoing research into innovative therapies and techniques will continue to broaden the scope of nerve repair applications in the healthcare sector.

By Distribution Channel

Hospitals:

Hospitals remain a primary distribution channel for nerve repair and regeneration products, accounting for a significant share of the market. As the main providers of surgical procedures involving nerve repair, hospitals are integral to the adoption of these products. The increasing number of surgeries performed in hospitals, coupled with the growing awareness of nerve repair solutions among medical professionals, is driving demand in this sector. Moreover, hospitals are investing in advanced surgical technologies and products to improve patient outcomes, further bolstering market growth. The collaboration between hospitals and manufacturers is crucial for ensuring the availability and accessibility of the latest nerve repair products in clinical settings.

Specialty Clinics:

Specialty clinics are rapidly emerging as significant distribution channels for nerve repair products due to their focused approach to specific medical conditions. These clinics often offer specialized care in areas such as neurology, orthopedics, and pain management, making them ideal venues for nerve repair solutions. The growing trend of outpatient surgical procedures has increased the relevance of specialty clinics in the nerve repair market. Additionally, the availability of expert practitioners in these clinics enhances the likelihood of incorporating advanced nerve repair products into treatment protocols. Patients seeking specialized care for nerve injuries are increasingly turning to these clinics, fueling demand for nerve repair products.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining prominence as an alternative distribution channel for nerve repair products. These facilities provide outpatient surgical services, allowing patients to receive treatments without the need for hospital admission. The rising preference for minimally invasive procedures and cost-effective healthcare solutions is driving the growth of ASCs in the nerve repair market. With the increasing number of surgical procedures being performed in ASCs, the demand for nerve repair products is expected to rise correspondingly. The convenience and efficiency offered by ASCs, along with their focus on patient-centric care, make them an attractive option for both patients and healthcare providers.

Online Platforms:

The advent of digital technology has transformed the distribution landscape for nerve repair products, with online platforms becoming increasingly significant. E-commerce has made it more convenient for healthcare providers to access a wide range of nerve repair solutions, facilitating quicker procurement and inventory management. The growing trend of telemedicine and remote consultations has also contributed to the increased utilization of online platforms for purchasing medical supplies. Additionally, the availability of detailed product information and reviews online helps healthcare professionals make informed purchasing decisions. As the digital marketplace continues to grow, online platforms are expected to play an increasingly vital role in the distribution of nerve repair products.

By Ingredient Type

Nerve Growth Factor:

Nerve growth factor (NGF) is a critical ingredient in various nerve repair products, playing a vital role in promoting the growth and survival of neurons. NGF has been extensively studied for its potential to enhance nerve regeneration after injury, making it a key component in many therapeutic solutions. The increasing awareness of the importance of NGF in nerve repair is driving the demand for products that incorporate this ingredient. Ongoing research into the mechanisms of NGF and its applications in clinical settings is expected to further expand its utilization in nerve repair therapies. The growing interest in regenerative medicine and targeted therapies is also propelling the market for NGF-based products.

Stem Cells:

Stem cells are at the forefront of regenerative medicine and are increasingly being integrated into nerve repair products. Their unique ability to differentiate into various cell types and promote tissue repair makes them a valuable resource in nerve regeneration therapies. The rise in research focused on stem cell applications in neurology has heightened interest in their use for nerve repair solutions. Additionally, advancements in stem cell technology and techniques are enhancing the effectiveness of these therapies, leading to improved patient outcomes. The potential for stem cells to provide long-lasting effects in nerve regeneration is driving their adoption in clinical practice, thereby expanding their market presence.

Platelet-rich Plasma:

Platelet-rich plasma (PRP) is emerging as a significant ingredient in nerve repair products, known for its healing properties and ability to promote tissue regeneration. PRP contains growth factors that can enhance nerve repair processes, making it a valuable addition to many surgical protocols. The increasing recognition of the importance of biological therapies in enhancing recovery outcomes is driving the demand for PRP-based nerve repair solutions. Furthermore, the simplicity of PRP preparation and its compatibility with various surgical techniques make it an attractive option for healthcare providers. As more clinicians incorporate PRP into their practices, the market for PRP-based nerve repair products is anticipated to grow.

Others:

In addition to nerve growth factor, stem cells, and platelet-rich plasma, several other ingredients are being explored in nerve repair products. These may include various bioactive compounds, synthetic materials, and natural extracts known for their neuroprotective and regenerative properties. The exploration of innovative ingredients is essential for developing novel nerve repair solutions that can cater to diverse patient needs. Ongoing research into the efficacy and safety of these ingredients is vital for their potential incorporation into clinical applications. As the field of nerve repair continues to advance, the range of ingredient types used in nerve repair products is expected to expand, enhancing treatment options for healthcare providers.

By Region

The regional analysis of the Nerve Repair and Regeneration market indicates that North America holds the largest market share, accounting for approximately 40% of the global revenue in 2025. This dominance can be attributed to a well-established healthcare infrastructure, high levels of healthcare expenditure, and the presence of key market players. The region is also witnessing a rise in neurological disorders, further propelling the demand for nerve repair products. The CAGR for the North American market is projected to be around 11% during the forecast period, reflecting robust growth driven by technological advancements and increased research activities in regenerative medicine.

Europe is poised to capture a significant share of the Nerve Repair and Regeneration market, estimated to be around 30% in 2025. The region benefits from a strong emphasis on healthcare innovation and the increasing prevalence of neurological disorders. Countries such as Germany, the UK, and France are leading contributors to this growth, supported by substantial investments in healthcare R&D and a growing geriatric population. The CAGR for the European market is projected to be approximately 9% during the forecast period, as healthcare systems adapt to incorporate the latest advancements in nerve repair technologies.

Opportunities

The Nerve Repair and Regeneration market presents numerous opportunities for growth, particularly in the realm of technological advancements. The development of innovative products, such as bioengineered nerve conduits and advanced neuromodulation devices, is driving market expansion. These technologies are not only improving the effectiveness of nerve repair but also enhancing patient safety and comfort during procedures. Moreover, the increasing collaboration between academic institutions and industry players is fostering research and innovation, leading to the introduction of novel therapies and treatment options. As healthcare professionals seek more effective solutions for nerve injuries and disorders, the opportunity for market players to capitalize on these advancements is significant.

Another promising opportunity lies in the rising global awareness of nerve repair and regeneration therapies. As patient education and understanding of neurological conditions improve, there is a growing demand for effective treatment options. This trend is particularly evident in emerging markets, where healthcare providers are increasingly adopting advanced nerve repair solutions to meet the needs of their patients. Additionally, government initiatives aimed at improving healthcare access and funding for research in regenerative medicine are likely to create new avenues for market growth. Companies that position themselves strategically in these emerging markets are well-poised to benefit from the growing demand for nerve repair products.

Threats

Despite the promising growth prospects of the Nerve Repair and Regeneration market, several threats could hinder its expansion. One of the primary challenges is the stringent regulatory environment governing the approval of medical devices and therapies. The lengthy and costly process for obtaining regulatory clearance can delay the entry of innovative products into the market, impacting the competitive landscape. Additionally, manufacturers must navigate complex compliance requirements, which can strain resources and deter investment in research and development. The need to ensure safety and efficacy during clinical trials can also pose challenges, particularly for novel therapies involving stem cells and gene editing technologies.

Another significant threat to the market is the potential for product recalls and liability issues. As the market for nerve repair products expands, the risk of adverse events associated with these devices increases. Negative publicity from product recalls can severely impact a company's reputation and market position. Furthermore, increasing competition from alternative treatment modalities, such as pharmacological therapies and physical rehabilitation, could divert attention and funding away from nerve repair solutions. In this dynamic landscape, companies must continuously innovate and differentiate their products to remain competitive and mitigate these threats.

Competitor Outlook

• Medtronic plc
• Stryker Corporation
• Abbott Laboratories
• Axogen Inc.
• Johnson & Johnson
• Teleflex Incorporated
• Boston Scientific Corporation
• Cambridge Medical Robotics
• Neurotech USA Inc.
• Integra LifeSciences Holdings Corporation
• RTI Surgical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.
• Regenesis Biomedical, Inc.
• Harvest Technologies Corporation
• Osiris Therapeutics, Inc.

The competitive landscape of the Nerve Repair and Regeneration market is characterized by a diverse array of companies, ranging from established medical device manufacturers to innovative startups. Key players such as Medtronic, Stryker, and Abbott Laboratories are leveraging their extensive research capabilities and market experience to develop cutting-edge nerve repair solutions. These companies are involved in substantial R&D investments aimed at enhancing the efficacy and safety of their products. Additionally, they are adopting strategic partnerships and collaborations to broaden their product portfolios and expand their market reach. The increasing focus on regenerative medicine and personalized therapies is driving competition in this segment, spurring innovation and the development of novel therapies that cater to diverse patient needs.

Major companies in the Nerve Repair and Regeneration market are not only focused on expanding their product offerings but are also prioritizing market expansion through geographical diversification. Companies like Axogen and Integra LifeSciences are actively pursuing international markets, particularly in emerging economies where the demand for advanced healthcare solutions is rising. These companies are establishing local partnerships and distribution networks to enhance their market presence and reach. Furthermore, the integration of digital technologies and telemedicine is reshaping the competitive landscape, with companies exploring new avenues for engaging with healthcare professionals and patients alike. The ability to leverage technology for enhanced patient outcomes will be a crucial factor for success in this evolving market.

In summary, the competitive outlook for the Nerve Repair and Regeneration market is shaped by ongoing innovation, strategic partnerships, and the drive for global expansion. As major players invest in R&D and seek to enhance their product portfolios, the market is expected to witness a surge in novel solutions tailored to improve nerve repair outcomes. Companies that can effectively navigate regulatory challenges, embrace technological advancements, and respond to the changing needs of healthcare providers and patients will be well-positioned to thrive in this dynamic landscape. As the search for effective nerve repair solutions continues, the landscape will likely evolve, presenting both challenges and opportunities for market participants.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Axogen Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Johnson & Johnson
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Neurotech USA Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Stryker Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Teleflex Incorporated
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Osiris Therapeutics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Cambridge Medical Robotics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Regenesis Biomedical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 RTI Surgical Holdings, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Zimmer Biomet Holdings, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Harvest Technologies Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Integra LifeSciences Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nerve Repair and Re generation Sales Market, By Application
    • 6.1.1 Neurosurgery
    • 6.1.2 Orthopedic Surgery
    • 6.1.3 Wound Healing
    • 6.1.4 Others
  • 6.2 Nerve Repair and Re generation Sales Market, By Product Type
    • 6.2.1 Nerve Conduits
    • 6.2.2 Nerve Protectors
    • 6.2.3 Nerve Wraps
    • 6.2.4 Nerve Connectors
    • 6.2.5 Neuromodulation Devices
  • 6.3 Nerve Repair and Re generation Sales Market, By Ingredient Type
    • 6.3.1 Nerve Growth Factor
    • 6.3.2 Stem Cells
    • 6.3.3 Platelet-rich Plasma
    • 6.3.4 Others
  • 6.4 Nerve Repair and Re generation Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Platforms

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Nerve Repair and Re generation Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nerve Repair and Re generation Sales market is categorized based on

By Product Type

• Nerve Conduits
• Nerve Protectors
• Nerve Wraps
• Nerve Connectors
• Neuromodulation Devices

By Application

• Neurosurgery
• Orthopedic Surgery
• Wound Healing
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Platforms

By Ingredient Type

• Nerve Growth Factor
• Stem Cells
• Platelet-rich Plasma
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Stryker Corporation
• Abbott Laboratories
• Axogen Inc.
• Johnson & Johnson
• Teleflex Incorporated
• Boston Scientific Corporation
• Cambridge Medical Robotics
• Neurotech USA Inc.
• Integra LifeSciences Holdings Corporation
• RTI Surgical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.
• Regenesis Biomedical, Inc.
• Harvest Technologies Corporation
• Osiris Therapeutics, Inc.